Long-Term Vascular Response to Everolimus-Eluting Stent: Five-year Follow-up Optical Coherence Tomography Study

Long-Term Vascular Response to Everolimus-Eluting Stent: Five-year Follow-up Optical Coherence Tomography Study - Long-Term Vascular Response to Everolimus-Eluting Stent: Five-year Follow-up Optical Coherence Tomography Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018860

Enrollment

Registered

2015-09-01

Start date

2015-03-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients had no cardiac adverse events in lesions treated with everolimus-eluting stents within 5-year after stent implantation.

Exclusion criteria

Exclusion criteria: 1) Patients presented with acute coronary syndrome 2) index target lesions with coronary artery bypass graft 3) index target lesions with in-stent restenosis 4) left ventricular ejection fraction <30% 5) eGFR <30 ml/min/1.73m2 6) inability to give informed consent

Design outcomes

Primary

Measure	Time frame
Quantitative parameters and qualitative characteristics of the neointima	—

Countries

Japan

Contacts

Public ContactShoichi Kuramitsu

Kokura Memorial Hospital Cardiology

kuramitsu@circulation.jp0935112000

Outcome results